Home > Boards > US OTC > Biotechs >

Oncolix Inc. (ONCX)

ONCX RSS Feed
Add ONCX Price Alert      Hide Sticky   Hide Intro
Moderator: laraz5, namtae
Search This Board: 
Last Post: 5/16/2019 12:40:09 PM - Followers: 202 - Board type: Free - Posts Today: 0



A pharmaceutical company in Harris County, Texas.
OTCQB: ONCX

14405 Walters Rd, Houston, TX 77014
(281) 402-3168
Contact Us
\

Oncolix, Inc. (Oncolix) is a clinical-stage biotechnology company

We are developing Prolanta™, a targeted therapeutic protein for the treatment of ovarian, breast and other cancers. The Company has a US FDA-cleared IND to commence human testing of Prolanta™ in our first indication, the treatment of ovarian cancer.  This clinical trial began in 2016. Preliminary data from the first dosing group (the low dose) of this trial suggest Prolanta is safe with some evidence of efficacy in a patient population that is difficult to treat. Prolanta™ is a prolactin receptor antagonist that has demonstrated significant efficacy in xenograft models through a unique mechanism of action, autophagy (see Our Science). In addition to ovarian cancer, there is strong preclinical evidence Prolanta™ will be effective in breast, prostate and other cancers.

The FDA has also approved the designation of Prolanta™ as an Orphan Drug for the treatment of ovarian cancer, which may allow reduced filing fees, federal tax credits and marketing exclusivity by the FDA.

Proudly partnered with Greenville Health System

Oncolix, Inc. (Oncolix) is a bio-pharmaceutical company originally established at the Greenville Health System through the innovative efforts of the Oncology Research Institute in conjunction with the GHS Cancer Center drug discovery program. Oncolix, now based in Houston, Texas, is currently focusing on phase one clinical trials of Prolanta™ - a targeted therapeutic protein for the treatment of breast and ovarian cancer. Prolanta™ was pioneered within the Oncology Research Institute (now known as the Clemson Biomedical Institute) at GHS in Greenville, SC.


Proudly partnered with MD Anderson Cancer Treatment Center


MD Anderson has been ranked the No. 1 hospital for cancer care in the nation by U.S. News & World Report’s “Best Hospitals” survey.

 

Oncolix patents

Oncolix has 30 patents in their patent portfolio, including 8 U.S patents.

\

 
ONCX Security Details
Share Structure
  Market Value1 $5,801,028 a/o Dec 01, 2017
Authorized Shares 950,000,000 a/o Dec 01, 2017
Outstanding Shares 103,877,936 a/o Dec 01, 2017
  -Restricted Not Available
  -Unrestricted Not Available
  Held at DTC Not Available
  Float 33,311,633 a/o Apr 06, 2017
  Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders
Shareholders of Record 101 a/o Apr 06, 2017

As per OTC markets. Updates are pending


Who is Oncolix, Inc.?

https://oncolixbio.com

April 2017 Company Presentation:
https://nebula.wsimg.com/8b544fcbb6f5bf5fb52c1c7e5a69eb81?AccessKeyId=D34B304F5C474C27E878&disposition=0&alloworigin=1

 

Early funding for Prolactin research was granted from the Susan G. Komen foundation and the U.S government.
More recent funding came from accredited investment including TEXAS TREASURY SAFEKEEPING TRUST CO and the Ernest Mario Family Trust.
Ernest Mario is an American pharmaceutical industry executive and the recipient of the 2007 Remington Honor Medal awarded by the American Pharmacists Association.

 

\

Ernest Mario is the former CEO of GlaxoSmithKilne NYSE: GSK.

He is also Rutgers University alumni who has had the Rutgers School of Pharmacy named after him.


Potential revenue moving forward.

 

 

The Oncolix Team

Management

\

\

Board Members

\

\

\

Prolanta Inventor

\

Company Advisors

\

\



 




 


This space reserved for updates.

 



https://www.otcm
arkets.com/edgar/GetFilingHtml?FilingID=12149068

ONCX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#18795  Sticky Note Can a REVERSE SPLIT be far behind? namtae 11/20/18 09:09:24 AM
#21159   Sell your shares for a loss. I'm holding MAGNETECH.SLNS 05/16/19 12:40:09 PM
#21158   news is due 02opida 05/16/19 12:27:10 PM
#21157   Seems the latest news was exactly a year ago... Billy055 05/15/19 11:50:03 PM
#21156   agree 02opida 05/15/19 02:13:16 PM
#21155   good for sympathy pop The Night Stalker 05/15/19 11:56:30 AM
#21154   PR should be forth coming soon too 02opida 05/14/19 11:01:16 AM
#21153   last yrs May / June 02opida 05/14/19 11:00:47 AM
#21152   GM. $ONCX Werbe 05/14/19 10:48:46 AM
#21151   morning ONCX 02opida 05/14/19 10:05:36 AM
#21150   https://www.stockscores.com/chart.asp?TickerSymbol=oncx&TimeRange=1095&Interval= The Night Stalker 05/11/19 01:05:47 AM
#21149   isn't there RS pending? The Night Stalker 05/11/19 01:03:53 AM
#21148   On mobile, not off the top of my Werbe 05/10/19 12:27:34 AM
#21147   isn't there RS pending? The Night Stalker 05/10/19 12:16:18 AM
#21146   OCNX is Controlled by Toxic Financers, the Execs laraz5 05/09/19 10:10:32 AM
#21145   The Longer The Tail!! The Higher We Sail!! Snake River Dog 05/09/19 09:19:41 AM
#21144   Yes, I read earlier this year if I Werbe 05/07/19 03:12:44 PM
#21143   Hi! per Dr. Gluck, the study is Finsman99 05/07/19 02:21:24 PM
#21142   I like that idea..maybe working for registration fee..lol tmcfo 05/07/19 10:51:16 AM
#21141   Pretty interesting that we see this "high" volume BeardOfWallSt 05/06/19 07:15:04 PM
#21140   Maybe the ceo will be there to sweep namtae 05/06/19 11:01:07 AM
#21139   will ONCX be at annual LD Micro Invitational 02opida 05/06/19 10:58:06 AM
#21138   Like your thinking. I was scouting some Werbe 04/30/19 12:13:16 PM
#21137   someone is loading maxm's shares while 2s remain BeardOfWallSt 04/30/19 11:54:45 AM
#21136   Huh?? Earlier this year they had problems Werbe 04/26/19 10:38:06 AM
#21135   Prolanta failed out of clinical trials? You can call laraz5 04/25/19 03:49:49 PM
#21134   I live close by to GHS. GHS is Juicyg 04/25/19 03:06:47 PM
#21133   Insane patents here, 40% of voting is controlled Werbe 04/25/19 02:06:36 PM
#21132   At least briefly...will stay tuned herbied47 04/25/19 12:49:38 PM
#21131   Just seeing the bid more then the ask. herbied47 04/25/19 12:48:37 PM
#21130   at least MAXM shifted back after a few BeardOfWallSt 04/25/19 11:41:19 AM
#21129   One PR. Sneeze or something and tell us herbied47 04/24/19 12:00:44 PM
#21128   https://www.scmp.com/news/world/united-states-canada/article/3007036/prominent-c laraz5 04/22/19 10:16:37 AM
#21127   Hopefully an Indictment? laraz5 04/17/19 11:25:30 AM
#21126   This will get a PR one of these herbied47 04/17/19 10:48:14 AM
#21125   The volume is up since yesterday. Over 20 jpennyman 04/16/19 02:03:19 PM
#21124   Is Redman and Payne just going to get laraz5 04/12/19 11:54:19 AM
#21123   Not so! namtae 04/12/19 11:27:07 AM
#21122   The good news is that any movement here jpennyman 04/12/19 11:22:07 AM
#21121   You would think with their patents they would've BeardOfWallSt 04/12/19 10:33:28 AM
#21120   morning ONCX 02opida 04/12/19 08:45:13 AM
#21119   some volume today ONCX 02opida 04/09/19 03:05:31 PM
#21118   someone picking up 1's 02opida 04/08/19 12:12:17 PM
#21117   high was over 02opida 04/07/19 03:04:38 PM
#21116   News on the event could come out 02opida 04/07/19 03:03:45 PM
#21115   Another ONCX to be present @ The 02opida 04/07/19 03:02:43 PM
#21114   Also, it's fun just hoping, and really with herbied47 04/05/19 11:03:19 AM
#21113   Oh wouldn't that be nice. PR of some herbied47 04/05/19 10:55:11 AM
#21112   Its possible because thats about all this CEO namtae 04/04/19 12:36:28 PM
#21111   Yeah I will hope with ya! Maybe we herbied47 04/04/19 11:59:19 AM
#21110   So Redman is now Spock? At least shareholders laraz5 04/04/19 09:32:37 AM
PostSubject